Asitri Dashboard Search Clinical Trials
The U.S. National Library of Medicine provides a database of clinical trials worldwide. Use the fields below to search the database. Expand your results and select terms or phrases and right-click to search using Google, MalaCards, MedlinePlus, PubMed, or Wikipedia.
Saved Searches
Choose Search
Basic Search
Clinical Trials Search Results
Search History:
Count: 14
Selected: 0
| NCT ID | Title | ||
|---|---|---|---|
| NCT06778564 | Stratification and Treatment in Early Psychosis Study - ENHANCE | ||
| NCT00530764 | A Study of Sativex® for Pain Relief in Patients With Advanced Malignancy. | ||
| NCT00391079 | Sativex Versus Placebo When Added to Existing Treatment for Central Neuropathic Pain in MS | ||
| NCT02544750 | An Open-label Extension Trial of Cannabidiol (GWP42003-P, CBD) for Seizures in Tuberous Sclerosis Complex (GWPCARE6) | ||
| NCT03202303 | Cannabidivarin (CBDV) vs. Placebo in Children With Autism Spectrum Disorder (ASD) | ||
| NCT02432612 | A Study to Assess the Pharmacokinetic (PK) Properties of Sativex® in Patients With Advanced Cancer | ||
| NCT01502046 | Neuroprotection by Cannabinoids in Huntington's Disease | ||
| NCT02240160 | A Randomised, Open-label, Three-way Crossover Study to Assess the Pharmacokinetics and Safety of Single Doses of Four Sprays of Sativex® in a Range of Oral pH Environments in Healthy Subjects | ||
| NCT04252586 | A Long-term Safety Study of Cannabidiol Oral Solution (GWP42003-P, CBD-OS) in Patients With Rett Syndrome | ||
| NCT02325024 | A Study to Evaluate the Pharmacokinetics Of Sativex® in Subjects With Severe Renal Impairment or End Stage Renal Disease, Compared to Matched Subjects With Normal Renal Function. | ||
| NCT04423341 | Effect of Non-psychoactive Cannabidiol as an Adjunct to Botulinum Toxin in Blepharospasm | ||
| NCT01262651 | Sativex® for Relieving Persistent Pain in Participants With Advanced Cancer | ||
| NCT01975688 | A Pharmacokinetic Study of Single Doses of Sativex in Treatment-induced Mucositis | ||
| NCT03848481 | CBDV vs Placebo in Children and Adults up to Age 30 With Prader-Willi Syndrome (PWS) |
